Loading clinical trials...
Loading clinical trials...
A Phase 2 Open-label Single Center Study to Evaluate the Efficacy of Apremilast for the Treatment of Moderate Hidradenitis Suppurativa
Conditions
Interventions
Apremilast
Locations
1
United States
Florida Academic Dermatology Centers
Coral Gables, Florida, United States
Start Date
July 1, 2016
Primary Completion Date
August 1, 2017
Completion Date
August 1, 2017
Last Updated
April 2, 2019
NCT06993233
NCT06888193
NCT07316192
NCT06768671
NCT06517732
NCT07228390
Lead Sponsor
Florida Academic Dermatology Centers
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions